Results 221 to 230 of about 180,771 (310)

Enitociclib (VIP152), venetoclax and prednisone in relapsed or refractory aggressive non‐Hodgkin lymphoma

British Journal of Haematology, EarlyView.
Max J. Gordon, Rahul Lakhotia, Stefania Pittaluga, Svetlana D. Pack, Anna Marie Juanitez, Ahmed Hamdy, Amy J. Johnson, Melanie M. Frigault, Raquel Izumi, Mark Raffeld, Mark Roschewski, Wyndham H. Wilson, Christopher Melani   +12 more
wiley   +1 more source

Toll‐Like Receptor Polymorphisms Influence Graft‐Versus‐Host Disease and Infection Risk After Single‐Unit Cord Blood Transplantation for Adults

European Journal of Haematology, EarlyView.
ABSTRACT Background Toll‐like receptors (TLRs) play a critical role in innate immunity by recognizing pathogen‐associated and damage‐associated molecular patterns. Genetic polymorphisms in TLR genes can modulate immune responses and have been implicated in the outcomes of allogeneic hematopoietic cell transplantation (HCT).
Takaaki Konuma, Megumi Hamatani‐Asakura, Seiko Kato, Shohei Andoh, Hirona Ichimura, Junichi Kuroda, Kaori Kondo, Kazuaki Yokoyama, Maki Monna‐Oiwa, Yasuhito Nannya, Satoshi Takahashi   +10 more
wiley   +1 more source

Fit, unfit, or frail? Now easier to tell for Hodgkin lymphoma. [PDF]

Haematologica
Moskowitz AJ.
europepmc   +1 more source

Core Needle Biopsies in Patients With Lymphoproliferative Malignancies: An Observational Single‐Center Cohort Study

European Journal of Haematology, EarlyView.
ABSTRACT In the diagnostic evaluation of suspected lymphoma, both core needle biopsy (CNB) and surgical excisional biopsy (SEB) are routinely employed for tissue sampling. While SEB remains the gold standard, CNB is a less invasive and more cost‐effective alternative. However, concerns persist regarding its diagnostic yield.
Blas Holger Mogensen, Torsten Holm Nielsen, Mette Ølgod Pedersen, Lise Mette Rahbek Gjerdrum, Tarec Christoffer El‐Galaly, Lars Møller Pedersen   +5 more
wiley   +1 more source

A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma. [PDF]

Clin Cancer Res
Strati P, Feng L, Tyshevich A, Shavronskaya D, Alesse J, English N, Sheehan E, Syzrantsev N, Nesmelov A, Zhuang TZ, Chihara D, Westin JR, Ahmed S, Fayad LE, Henderson J, Dent K, McChesney E, Neelapu SS, Flowers CR.   +18 more
europepmc   +1 more source

Cardiovascular Challenges in Chronic Lymphocytic Leukemia (CLL) Patients Undergoing Bruton Tyrosine Kinase (BTK) Inhibitor Therapy

European Journal of Haematology, EarlyView.
ABSTRACT Background/Objectives Bruton tyrosine kinase inhibitors (BTKis) have revolutionized treatment for chronic lymphocytic leukemia (CLL), but cardiovascular (CV) toxicities pose significant challenges. Second‐generation BTKis offer improved target specificity, yet CV risks persist.
Stefano Oliva, Stefano Molica
wiley   +1 more source

Estimating efficacy of favezelimab plus pembrolizumab relative to pembrolizumab in anti-PD-1-refractory Hodgkin lymphoma. [PDF]

Blood Adv
Armand P, Zinzani PL, Timmerman J, Johnson NA, Lavie D, Thiagarajan K, Topp BG, Pillai P, Herrera AF.   +8 more
europepmc   +1 more source

Herpes Zoster in Hematological Disorders: Pathogenesis, Risk Stratification, and Emerging Strategies for Prevention and Immunization

European Journal of Haematology, EarlyView.
ABSTRACT Background Herpes zoster (HZ), resulting from reactivation of latent varicella‐zoster virus (VZV), imposes a significant burden on immunocompromised patients, particularly those with hematological malignancies and recipients of hematopoietic stem cell transplants (HSCT).
Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Santino Caserta, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source

Association Between Moraxella catarrhalis and Nodular Lymphocyte-Predominant Hodgkin Lymphoma. [PDF]

Am J Hematol
Lossos IS, Jiang X, Patel K, Moalem KN, Laser J, Song JY, Perry AM, Chapman JR.   +7 more
europepmc   +1 more source

Emerging Techniques in Minimally Invasive Surgery in Hematologic Malignancies

European Journal of Haematology, EarlyView.
ABSTRACT Hematologic malignancies represent the most common cancers in children. While the mainstays of treatment are chemotherapy and potentially hematopoietic stem cell transplant, minimally invasive surgery (MIS) has a role in the diagnosis and management of complications related both to disease and therapy as well as common pediatric surgical ...
Alejandro Chara, Katlyn G. McKay, Harold N. Lovvorn III, Joseph C. Fusco   +3 more
wiley   +1 more source